Regulatory T cell metabolism in atherosclerosis

Jeroen Baardman, Esther Lutgens

Research output: Contribution to journalReview articlepeer-review


Regulatory T cells (Tregs) are capable of suppressing excessive immune responses to prevent autoimmunity and chronic inflammation. Decreased numbers of Tregs and impaired suppressive function are associated with the progression of atherosclerosis, a chronic inflammatory disease of the arterial wall and the leading cause of cardiovascular disease. Therefore, therapeutic strategies to improve Treg number or function could be beneficial to preventing atherosclerotic disease development. A growing body of evidence shows that intracellular metabolism of Tregs is a key regulator of their proliferation, suppressive function, and stability. Here we evaluate the role of Tregs in atherosclerosis, their metabolic regulation, and the links between their metabolism and atherosclerosis.

Original languageEnglish (US)
Article number279
Pages (from-to)1-15
Number of pages15
Issue number7
StatePublished - Jul 2020


  • Atherosclerosis
  • Foxp3
  • Hypercholesterolemia
  • Immunometabolism
  • Metabolism
  • T cells
  • Tregs

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology


Dive into the research topics of 'Regulatory T cell metabolism in atherosclerosis'. Together they form a unique fingerprint.

Cite this